Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry)

► We report data from large, multicentre registry on patients undergoing primary PCI. ► Early abciximab before PCI enhances reperfusion in diabetic patients with STEMI. ► Early abciximab before PCI improves clinical outcome in diabetic patients with STEMI.